Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture
NCT05877066 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 130
Last updated 2024-04-16
Summary
This is an observational study, meaning participants will not receive any investigational treatment as part of this study.
Researchers will collect real-world data (RWD), based on usual care, to gain a more in-depth knowledge of the natural history and the treatment outcomes of Dupuytren's Contracture (DC) to evaluate the management of DC.
Conditions
- Dupuytren's Contracture
Sponsors & Collaborators
-
Pulse Infoframe
collaborator INDUSTRY -
Endo Pharmaceuticals
lead INDUSTRY
Principal Investigators
-
Medical Information · Endo Pharmaceuticals
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-14
- Primary Completion
- 2024-02-26
- Completion
- 2024-02-26
Countries
- United States
Study Locations
More Related Trials
-
Post Approval Commitment Study
NCT01444729 ·Status: COMPLETED
-
Radiation Therapy for Dupuytren's Contracture Following Non-Surgical Release
NCT06330545 ·Status: RECRUITING ·Phase: NA
-
Trial Comparing Treatment Strategies in Dupuytren's Contracture
NCT03192020 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture
NCT05440240 ·Status: RECRUITING ·Phase: PHASE4
-
Hand Therapy or Not Following Collagenase Treatment for Dupuytren's Contracture?
NCT03580213 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Percutaneous Needle Aponeurotomy
NCT03797690 ·Status: RECRUITING ·Phase: NA
-
Natural Disease Progress of Dupuytren Disease
NCT01923103 ·Status: COMPLETED
-
Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease
NCT00004409 ·Status: COMPLETED ·Phase: PHASE2
-
Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF
NCT02647619 ·Status: COMPLETED ·Phase: PHASE4
-
Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease
NCT00014742 ·Status: COMPLETED ·Phase: PHASE3
-
Health-Related Quality of Life in Patients With Dupuytren's Disease
NCT00468949 ·Status: COMPLETED
-
Safety and Efficacy of Delayed Manipulation After Xiaflex Treatment in Subjects With Dupuytren's Contracture
NCT01226121 ·Status: TERMINATED ·Phase: PHASE4
-
Retreatment of Recurrent Dupuytren's Contractures
NCT01498640 ·Status: COMPLETED ·Phase: PHASE4
-
Dupuytren's Disease and Extracorporeal Shockwave Therapy (DupuyShock-2010)
NCT01184586 ·Status: UNKNOWN ·Phase: PHASE2
-
Micronerves in Dupuytren and the Impact of Its Dissection on Recurrence
NCT06142929 ·Status: RECRUITING
-
Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture
NCT01538017 ·Status: COMPLETED ·Phase: NA
-
AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Dupuytren's Contracture
NCT00528606 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules
NCT02193828 ·Status: COMPLETED ·Phase: PHASE2
-
Nodular Shrinking in Dupuytren Disease
NCT06321991 ·Status: RECRUITING ·Phase: PHASE2
-
The Effects of Prophylactic Limited Palmar Fasciectomy on Surgical Outcomes and Scarring
NCT03155854 ·Status: RECRUITING ·Phase: NA
-
Administration of Two Injections for Multiple Dupuytren's Contractures
NCT01407068 ·Status: COMPLETED ·Phase: PHASE3
-
BOND Study: the Benefit Of Night Splinting in Dupuytrens'
NCT03031080 ·Status: WITHDRAWN ·Phase: NA
-
Carpal Tunnel Syndrome: Diagnosis and Treatment Trial
NCT00032227 ·Status: COMPLETED ·Phase: NA
-
Ultrasound Features of Dupuytren's Disease
NCT06956027 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease
NCT00528840 ·Status: COMPLETED ·Phase: PHASE3